Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty.

@article{Mommsen2014EffectsOT,
  title={Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty.},
  author={Philipp Mommsen and Matthias Doering and Ehrenfried R O Hrs and Claus C. Egidy and Thorsten A Gehrke and Christian Krettek and Daniel Oliver Kendoff},
  journal={Technology and health care : official journal of the European Society for Engineering and Medicine},
  year={2014},
  volume={22 6},
  pages={901-8}
}
BACKGROUND Low-molecular-weight heparins (LMWH), e.g. enoxaparin, represent the standard thromboprophylactic agents in Europe after total hip replacement. The oral direct thrombin inhibitor dabigatran etexilate provides comparable effectiveness and safety. The present study aimed to evaluate the influence of dabigatran etexilate on perioperative blood loss… CONTINUE READING